Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Triumvira Immunologics raises funds for T-cell therapy programmes
Triumvira Immunologics completes Series A extension financing to accelerate development of TAC-T cell therapy programmes. Credit: mwooten from Pixabay.
Triumvira Immunologics completes Series A extension financing to accelerate development of TAC-T cell therapy programmes. Credit: mwooten from Pixabay.